World News: 19:10 GMT Monday 16th April 2018. [Dynavax Technologies Corporation via Globe Newswire via SPi World News]
BERKELEY Calif April 16 2018 GLOBE NEWSWIRE -- Dynavax Technologies Corporation NASDAQDVAX today announced data from its ongoing Phase 1b2 study investigating SD-101, Dynavaxs intratumoral TLR9 agonist in combination with KEYTRUDAreg , an a...
Globe Newswire: 19:10 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.